175 related articles for article (PubMed ID: 25856976)
1. [Tuberculosis annual report 2012--(4) Tuberculosis treatment and outcomes].
; ;
Kekkaku; 2014 Dec; 89(12):825-34. PubMed ID: 25856976
[TBL] [Abstract][Full Text] [Related]
2. [Tuberculosis Annual Report 2011--(4) Tuberculosis treatment and treatment outcomes].
Kekkaku; 2013 Sep; 88(9):677-86. PubMed ID: 24298695
[TBL] [Abstract][Full Text] [Related]
3. [TUBERCULOSIS ANNUAL REPORT 2013--(4) Tuberculosis Treatment and Treatment Outcomes].
; ;
Kekkaku; 2015 Jul; 90(7):595-604. PubMed ID: 26630730
[TBL] [Abstract][Full Text] [Related]
4. [TUBERCULOSIS ANNUAL REPORT 2014 -(4) Tuberculosis Treatment and Treatment Outcomes -].
Tuberculosis Surveillance Center
Kekkaku; 2016 Sep; 91(6):551-559. PubMed ID: 30646457
[TBL] [Abstract][Full Text] [Related]
5. [Tuberculosis Annual Report 2008--Series 9. Treatment of TB (2)].
Tuberculosis Surveillance Center, RIT, JATA
Kekkaku; 2010 Jul; 85(7):643-6. PubMed ID: 20715550
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis annual report 2009--series 9. Treatment of TB (2)].
; ;
Kekkaku; 2012 Apr; 87(4):351-5. PubMed ID: 22708130
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculosis annual report 2010--(9) Treatment of tuberculosis-2].
; ;
Kekkaku; 2013 Apr; 88(4):439-43. PubMed ID: 23819321
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis annual report 2009 --series 10. Treatment outcome and TB deaths].
; ;
Kekkaku; 2012 May; 87(5):415-9. PubMed ID: 22696774
[TBL] [Abstract][Full Text] [Related]
10. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
Masuyama H; Igari H
Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis annual report 2010 - (8) treatment of tuberculosis-1].
Tuberculosis Surveillance Center (TSC), RIT, JATA
Kekkaku; 2013 Mar; 88(3):311-4. PubMed ID: 23672173
[TBL] [Abstract][Full Text] [Related]
12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
13. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
Masuyama H; Takase A; Aoki M; Shimao T
Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis annual report 2009--series 8. Treatment of TB(1)].
Tuberculosis Surveillance Center
Kekkaku; 2012 Feb; 87(2):57-60. PubMed ID: 22514941
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis annual report 2008--series 10. Treatment outcome and TB deaths].
Research Institute of Tuberculosis, JATA
Kekkaku; 2010 Aug; 85(8):683-6. PubMed ID: 20845689
[TBL] [Abstract][Full Text] [Related]
16. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of the future epidemiological situation of tuberculosis in Japan].
Ohmori M; Yoshiyama T; Ishikawa N
Kekkaku; 2008 Apr; 83(4):365-77. PubMed ID: 18516900
[TBL] [Abstract][Full Text] [Related]
18. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
